<DOC>
	<DOC>NCT01861535</DOC>
	<brief_summary>To evaluate the efficacy (defined as complete clinical response at 6 months) of imiquimod vs. standard treatment (surgery) for vulvar intraepithelial neoplasia (VIN).</brief_summary>
	<brief_title>Primary Imiquimod Treatment Versus Surgery for Vulvar Intraepithelial Neoplasia</brief_title>
	<detailed_description />
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Carcinoma in Situ</mesh_term>
	<mesh_term>Imiquimod</mesh_term>
	<criteria>Histologically confirmed VIN (only usual type, formerly VIN 23) Visible, measurable lesion(s) Contraception (for premenopausal women) Evidence of invasion History of cancer or severe inflammatory dermatosis of the vulva Pregnancy, lactation Immunodeficiency Any treatment for VIN within the previous three months Known hypersensitivity to imiquimod</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>VIN</keyword>
	<keyword>Imiquimod</keyword>
	<keyword>Surgery</keyword>
	<keyword>HPV</keyword>
	<keyword>Patient satisfaction</keyword>
</DOC>